. AcrIIA5 dependent sgRNA cleavage, Related to Figure 3 . (A) Size-exclusion chromatograms of His-tagged Nme1Cas9-sgRNA co-expressed with AcrIIA5 (green line) or no anti-CRISPR protein (blue line). (B) Fractions indicated with numbers in (A) were analyzed on a 15% Tris-tricine polyacrylamide gel using SDS-PAGE gel followed by Coomassie staining (top panel) and a denaturing polyacrylamide/Urea gel followed by SYBR TM Gold staining (lower panel). (C) Nucleotide sequences of reverse transcribed RNA molecules bound to Nme1Cas9 in the presence or absence of AcrIIA5, as indicated. The alignment was generated using MUSCLE (Edgar, 2004) . Nucleotides are colored red (G), green (A), blue (T) or yellow (C), depending on their chemical composition, and gaps are indicated by dashes. Adaptors and primers from the NEBnext Small RNA sequencing kit are annotated below the aligned sequences. The sgRNA elements are also annotated. (D) To ascertain whether AcrIIA5 induces Nme1Cas9 to cleave its bound sgRNA, we expressed mutant Nme1Cas9 proteins with amino acid substitutions in the domains that mediate nuclease activity; the RuvC domain (D16A), the HNH domain (H588A), and a double mutant (dm) with substitutions in both domains (D16A/H588A) (Zhang et al., 2015) . Wild-type (WT) or mutant versions His6-Nme1Cas9 were co-expressed with pCDF-1b (no Acr), AcrIIC1 or AcrIIA5, and then purified by Ni-NTA chromatography. Ribonucleoprotein complexes were analyzed by a 15% Tristricine polyacrylamide gel using SDS-PAGE and visualized by stain-free imaging. Complexes were also resolved on a 12.5% polyacrylamide/Urea gel and the sgRNA visualized by SYBR TM Gold staining. When the Nme1Cas9 mutants were co-expressed with AcrIIA5, the sgRNA was cleaved in the same manner as with wild-type Nme1Cas9. These results showed that Nme1Cas9 does not catalyze the AcrIIA5-induced cleavage of sgRNA by utilizing its established nuclease domains.
Supplementary Figure S1

Figure S2. AcrIIA5 homologs show broad Cas9 inhibition and sgRNA cleavage, Related to Figures 1 and 3 and STAR Methods.
(A) A multiple sequence alignment of AcrIIA5 homologs (Streptococcus phage D1126 (SthD1126: AVO22762.1); Enterococcus faecalis (Efa: WP_002415475.1); Dolosigranulum pigrum (Dpi: WP_112790338.1); Lactobacillus saerimneri (Lsa: WP_027827173.1); Granulicatella sp. 572 (G572: WP_049555364.1) generated by MUSCLE. Conserved amino acid residues are highlighted and the consensus conservation logos are shown. Red asterisks indicate amino acid residues that were mutated as described in Supplementary Figure S3 . (E) His6-Nme1Cas9 or (F) His6-SpyCas9 was co-expressed and co-purified with pCDF-1b (no Acr), or AcrIIA5 homologs. Ribonucleoprotein complexes were analyzed by a 15% Tris-tricine polyacrylamide gel using SDS-PAGE followed by Coomassie staining (top) and a polyacrylamide/Urea gel stained with SYBR TM Gold (bottom). It should also be noted that AcrIIA5Efa binds non-specifically to the Ni-NTA resin. Thus, the observed visible band of this protein is not a result of its binding to Cas9. (A) With the idea that AcrIIA5 might be a nuclease, we identified completely conserved residues (Supplementary Figure S2A ) that could be involved in binding to metal or nucleic acids (e.g. Asp, His, Asn, Arg, or Lys). We constructed three mutants bearing amino acid substitutions at some of these positions. Ten-fold serial dilutions of phage Mu lysate were spotted on lawns of bacteria expressing the indicated AcrIIA5 mutant. The results showed that these mutations completely (D50R62 and D74K85K88) or nearly completely ( 
